ARTICLE | Clinical News
Topsalysin: Additional Phase IIa data
July 18, 2016 7:00 AM UTC
Data from an open-label, U.K. Phase IIa trial in 18 patients with localized prostate cancer showed that a single intraprostatic injection of topsalysin led to complete ablation of the targeted tumor w...